Inhoud
Week 1………………………………………………………………………………………...2
Handboek H1: Wat is psychose? ………………………………………………………………2
Handboek H2: Hoe ontstaat een psychose? ……………………………………………………7
Handboek H6: Een psychose vaststellen……………………………………………………….8
Week 2……………………………………………………………………………………….10
Handboek H3: Overmatige achterdocht (paranoia)……………………………...……………10
Handboek H11: Stigmatisering……………………………………………………………….12
Handboek H18: Herstel en ervaringsdeskundigheid………………………………………….15
Week 3……………………………………………………………………………………….16
Handboek H9: Organisatie van zorg………………………………………………………….16
Handboek H17: Familie………………………………………………………………………19
Week 4……………………………………………………………………………………….22
Handboek H5: Cognitie………………………………………………………………………22
Handboek H12: Medicatie……………………………………………………………………24
Huhn et al. (2019): Comparative efficacy and tolerability of 32 oral antipsychotics for the acute
treatment of adults with multi-episode schizophrenia………………………………………...27
Week 5……………………………………………………………………………………….28
Handboek H8: Praten met een patiënt met psychose………………………………………….28
Handboek H13: Cognitieve gedragstherapie…………………………………………………30
Week 6……………………………………………………………………………………….33
Handboek H4: Stemmen horen (auditief-verbale hallucinaties)……………………………...33
Week 7……………………………………………………………………………………….36
Handboek H7: Preventie van een eerste psychose…………………………………………….36
Van der Gaag et al. (2019): CBT in the prevention of psychosis and other severe mental
disorders in patients with an at risk mental state………………………………………………37
Week 8……………………………………………………………………………………….37
Handboek H19: Evidentie voor de behandelingen……………………………………………37
Week 9……………………………………………………………………………………….39
Handboek H10: Hoe behandel je psychose en comorbiditeit?..................................................39
Handboek H14: Trauma, posttraumatische stress en psychose……………………………….39
Van den Berg et al. (2015): Prolonged exposure vs. eye movement desensitisation and
reprocessing vs. waiting list for posttraumatic stress disorder in patients with a psychotic
disorder ………………………………………………………………………………………42
Week 10……………………………………………………………………………………...42
Handboek H15: Derde generatie CGT………………………………………………………..42
Handboek H16: e-Health……………………………………………………………………..47
1
, Week 1
Handboek H1: Wat is psychose?
Tijdens een psychose is iemand het contact met de gedeelde realiteit kwijt. Hierbij horen
positieve symptomen (wanen, hallucinaties en desorganisatie) en negatieve symptomen (de
afwezigheid van normaal gedrag). Een aantal verschillende psychotische stoornissen worden
omschreven in de DSM-5:
• Kortdurende psychotische stoornissen (1 dag – 1 maand).
• Schizofreniforme stoornis (1 maand – 6 maanden).
• Schizofrenie (> 6 maanden).
• Schizoaffectieve stoornis (psychose i.c.m. stemmingsepisoden).
• Waanstoornis (7 typen).
• Psychotische stoornis door een middel.
• Psychotische stoornis door een somatische aandoening.
• Katatonie (als specifier bij een andere stoornis of door somatiek).
• Andere gespecificeerde schizofreniespectrumstoornis.
• Ongespecificeerde schizofreniespectrumstoornis.
DSM-5 Criteria for Schizophrenia
A. Two (or more) of the following, each present for a significant portion of time
during a 1-month period (or less if successfully treated). At least one of these must
be (1), (2), or (3):
1. Delusions.
2. Hallucinations.
3. Disorganised speech (e.g., frequent derailment or incoherence).
4. Grossly disorganised or catatonic behaviour.
5. Negative symptoms (i.e., diminished emotional expression or avolition).
B. For a significant portion of the time since the onset of the disturbance, level of
functioning in one or more major areas, such as work, interpersonal relations, or
self-care, is markedly below the level achieved prior to the onset (or when the onset
is in childhood or adolescence, there is failure to achieve expected level of
interpersonal, academic, or occupational functioning).
C. Continuous signs of the disturbance persist for at least 6 months. This 6-month
period must include at least 1 month of symptoms (or less if successfully treated)
that meet Criterion A (i.e., active-phase symptoms) and may include periods of
prodromal or residual symptoms. During these prodromal or residual periods, the
signs of the disturbance ay be manifested by only negative symptoms or by two or
more symptoms listed in Criterion A present in an attenuated form (e.g., odd
beliefs, unusual perceptual experiences).
D. Schizoaffective disorder and depressive or bipolar disorder with psychotic features
have been ruled out because either 1) no major depressive or manic episodes have
occurred concurrently with the active-phase symptoms, or 2) if mood episodes have
occurred during the active-phase symptoms, they have been present for a minority
of the total duration of the active and residual periods of the illness.
E. The disturbance is not attributable to the physiological effects of a substance (e.g., a
drug of abuse, a medication) or another medical condition.
2